A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer ...

The strong allogeneic response to donor MHC molecules in transplantation and the weak response to tumor antigens represent two important and divergent but potentially interactive immune responses.

A study is seeking to contribute to cancer immunotherapy in the development of vaccines against deadly cancer types such as ...

However, for patients with ‘cold’ tumors that express low levels of tumor-infiltrating ... a broad swath of tumor antigens to the immune system and prime T cell recognition of these antigens.

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...

In this case, the tumor on the right was irradiated; the left one was not ... Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova, A, Bander N, Lewis JS, Grimm J (2011) Targeting the internal ...